Decreased levels of most coagulation factors and thrombocytopenia are the main
haemostatic abnormalities of cirrhosis. As a consequence, this condition was, until recently …

Inflammation has been recognised to both decrease beta cell insulin secretion and increase
insulin resistance. Circulating cytokines can affect beta cell function directly leading to …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is characterized by increased
risk of cardiovascular events and liver-fibrosis. Both could be explained by a procoagulant …

Non-alcoholic fatty liver disease (NAFLD) has been recognized as a major health burden. It
is the most important cause of chronic liver disease and a major independent cardiovascular …

Non-alcoholic fatty liver disease (NAFLD) has a growing prevalence in recent years. Its
association with cardiovascular disease has been intensively studied, and certain …

Atrial fibrillation (AF) and venous thromboembolism (VTE) are highly prevalent and relevant
healthcare issues. Direct oral anticoagulants (DOACs) are now the first-choice for …

Enteropathic arthritis (EA) is a spondyloarthritis (SpA) which occurs in patients with
inflammatory bowel diseases (IBDs) and other gastrointestinal diseases. Diagnosis is …

PsA is an axial and/or peripheral inflammatory arthritis associated with psoriasis, included in
the group of spondylarthritides. It has been suggested that PsA could be a systemic disease …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is associated with an
increased risk of thrombosis. However, it remains unclear if hypercoagulability contributes to …

Objective: Patients with cirrhosis are at increased risk for venous thromboembolism (VTE)
and portal vein thrombosis (PVT). Cirrhosis due to non-alcoholic steatohepatitis (NASH) …